Año: 2021
Journal Impact Factor (JIF): 51.7690
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
ONCOLOGY | SCIE | 5/245 | Q1 | T1 | D1 |
Año: 2021
Journal Citation Indicator (JCI): 4,810
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
ONCOLOGY | 9/318 | Q1 | T1 | D1 | 97,33 |
Año:
2021
CiteScore:
47,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Hematology | 2/126 | Q1 | T1 | D1 |
Oncology | 6/360 | Q1 | T1 | D1 |
SJR año:
2021
Factor de Impacto:
8,590
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Hematology | 2/141 | Q1 | T1 | D1 |
Medicine (miscellaneous) | 12/2548 | Q1 | T1 | D1 |
Oncology | 7/404 | Q1 | T1 | D1 |
# | Autor | Afiliación |
---|---|---|
1 | Slamon, D. J. | David Geffen School of Medicine at UCLA (United States) |
2 | Neven, P. | KU Leuven– University Hospital Leuven (Belgium) |
3 | Chia, S. | British Columbia Cancer Agency (Canada) |
4 | Jerusalem, G. | Centre Hospitalier Universitaire de Liege (Belgium) |
5 | De Laurentiis, M. | Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli (Italy) |
6 | Im, S. | Seoul National University Hospital (South Korea) |
7 | Petrakova, K. | Masaryk Memorial Cancer Institute (Czech Republic) |
8 | Valeria Bianchi, G. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
9 | Martín, M. | Universidad Complutense de Madrid (Spain) |
10 | Nusch, A. | Practice for Hematology and Internal Oncology (Germany) |
11 | Sonke, G. S. | The Netherlands Cancer Institute (Netherlands) |
12 | Cruz-Merino, L. de la | Hospital Universitario Virgen Macarena (Spain) |
13 | Beck, J. T. | Highlands Oncology Group (United States) |
14 | Ji, Y. | Novartis International AG (Switzerland) |
15 | Wang, C. | Novartis International AG (Switzerland) |
16 | Deore, U. | Novartis International AG (Switzerland) |
17 | Chakravartty, A. | Novartis International AG (Switzerland) |
18 | Zarate, J. P. | Novartis International AG (Switzerland) |
19 | Taran, T. | Novartis International AG (Switzerland) |
20 | Fasching, P. A. | Universitätsklinik Erlangen und Medizinische Fakultät (Germany) |